Differing epidemiology of two major healthcare-associated meticillin-resistant Staphylococcus aureus clones

The Journal of Hospital Infection
C J JeremiahS Y Tong

Abstract

Two meticillin-resistant Staphylococcus aureus (MRSA) clones, sequence type (ST) 22 and ST239, have successfully spread globally. Across Australia, ST22 has supplanted ST239 as the main healthcare-associated MRSA. To understand the reasons underlying this shift, the epidemiology and clinical features of infections due to ST22 and ST239 MRSA isolates from a tertiary hospital in Melbourne, Australia were compared. Over six months, consecutive MRSA isolates with clinical data were collected from specimens referred to Alfred Health Pathology (AHP). Isolates were genotyped by a multi-locus-sequence-typing-based high-resolution melting method. Three hundred and twenty-eight of 1079 (30%) S. aureus isolated by AHP were MRSA. Of these, 313 were genotyped; 78 (25%) were clonal complex (CC) 22 (representing ST22) and 142 (45%) were CC239 (representing ST239). Common clinical syndromes included skin or soft tissue, respiratory tract and osteo-articular infections. On multi-variate logistic regression, compared with CC239, CC22 was associated with older patients [adjusted odds ratio (aOR) 1.04 for each year increase, 95% confidence interval (CI) 1.02-1.07)], and patients from subacute hospitals (aOR 2.7, 95% CI 1.2-5.8) or long-term care f...Continue Reading

References

Oct 9, 2004·Journal of Clinical Microbiology·Geoffrey W CoombsUNKNOWN Australian Group for Antimicrobial Resistance
May 7, 2005·American Journal of Infection Control·Linda McKibbenUNKNOWN Heathcare Infection Control Practices Advisory Committee
Jul 16, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Linda McKibbenUNKNOWN Healthcare Infection Control Practices Advisory Committee
Feb 9, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·T J KiddS C Bell
Sep 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrew F Shorr
Sep 29, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Oriol ManuelDeepali Kumar
Oct 8, 2009·The Journal of Antimicrobial Chemotherapy·Olivier DenisMarc J Struelens
Dec 3, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E Tacconelli
Dec 26, 2009·The Journal of Antimicrobial Chemotherapy·Matthew J EllingtonAlan P Johnson
Jan 23, 2010·Science·Simon R HarrisStephen D Bentley
Sep 21, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Giuseppe IppolitoRichard P Wenzel
Dec 18, 2010·International Journal of Antimicrobial Agents·Barry CooksonUNKNOWN International Society of Chemotherapy (ISC)
May 6, 2011·The Journal of Antimicrobial Chemotherapy·Alan P Johnson
Sep 16, 2011·Current Opinion in Pulmonary Medicine·Elliott C Dasenbrook
Sep 29, 2011·The Journal of Antimicrobial Chemotherapy·David WyllieDerrick Crook
Mar 8, 2012·Epidemiology and Infection·J TeoUNKNOWN Network for Antimicrobial Resistance Surveillance (Singapore)
Jul 5, 2012·The Journal of Antimicrobial Chemotherapy·Gwenan M KnightJodi A Lindsay
Aug 21, 2012·PloS One·Rossella BaldanDaniela M Cirillo

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.